Diabetes Care in The Netherlands: - Novo Nordisk
Diabetes Care in The Netherlands: - Novo Nordisk
Diabetes Care in The Netherlands: - Novo Nordisk
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ContentsSummarized f<strong>in</strong>d<strong>in</strong>gs and recommendations<strong>The</strong> opportunity• <strong>Diabetes</strong> is a major and underestimated source of medical costs and lost productivity• <strong>Diabetes</strong> care <strong>in</strong> <strong>The</strong> <strong>Netherlands</strong> has reached a high level of quality, but there is still opportunity for further improvement• Further improv<strong>in</strong>g health of patients may lead to EUR 1.5-2 B of economic benefits <strong>in</strong> 2020<strong>The</strong> road• Ref<strong>in</strong>e economic <strong>in</strong>centives to encourage <strong>in</strong>tegrated care and quality improvement• Engage employers, UWV and participative care <strong>in</strong> diabetes care• Engage the patient’s social network to support self management• Introduce conditional market access models for new therapies and medication to assess behavioural impactAppendix: list of sources49